New cell-laden bioink, comprised of tightly-packed, flake-shaped microgels and living cells, the production of cell-rich 4D bioconstructs that can change shape under physiological conditions. Where ...
Last year, during the Global Synthetic Biology (SynBioBeta) conference, Ansa Biotechnologies’ CEO Jason Gammack introduced attendees to the company’s first product—600 bp synthetic DNA constructs.
Every researcher knows the frustration: your groundbreaking experiment is on hold because the DNA sequence you need is "unmanufacturable". Or worse, after weeks of waiting, the oligos arrive with ...